TMCnet News
Libero Holdings Announces the Formation of Dermal TherapiesBEVERLY HILLS, Calif. --(Business Wire)-- Libero Holdings today announced the formation of Dermal Therapies. Dermal Therapies is the first company incubated out of Libero Holdings and is focused initially on the development of a non-invasive dermal closure platform that achieves surgical closure without using sutures or staples. Dermal Therapies has underlying intellectual property upon which it will focus initial development efforts. "Surgical staple delivery systems are very expensive and suture placement can be time consuming," said Tim Lennon, Managing Partner and Co-Founder of Libero Holdings. "We are dedicated to the development of a cost-effective, non-invasive system to achieve a better and more efficient method of primary dermal closure. It's our vision that such a platform will result in a better cosmetic outcome for the patient." According to published data, 234 million major surgical procedures are performed worldwide each year. The global surgical equipment market was valued at USD $.43 billion in 2012, with the surgical suture and staples segment accounting for the largest share (55.6%) of the total surgical equipment market revenue. About Libero Holdings Libero Holdings is a privately held investment group that funds early stage companies in the medical device marketplace. Its focus is to partner with entrepreneurs and industry professionals to develop and commercialize proprietary technologies. Libero looks to invest in technologies that will offer substantial innovation, differentiation and clinical improvements over existing products in the market, in addition to delivering economic benefits to the healthcare facility. The technologies Libero targets will typically require a less stringent regulatory pathway and compete in smaller to midsize markets (<$500 million). Libero has a unique business model that leverages its expertise, not only in the design, development and regulatory processes, but also through to product commercialization. Libero's in-depth understanding of the business, science, and market opportunity allows it to customize a project team around a novel technology. For more information on Libero Holdings, please visit http://www.liberoholdings.com For more information on Dermal Therapies, please visit http://www.dermaltherapies.net
|
